Cellular composition of leukapheresis samples was determined by flow cytometry using the following antibodies (20 min at 4°C): CD3 (BD), CD19 (BioLegend), and CD56 (BioLegend).
Expression of exhaustion markers was determined by flow cytometry using the following antibodies (20 min at 4°C): CD3 (BD), RQR8 (Qbend10 antibody; R&D), CD8 (BioLegend), LAG3 (Enzo Life Sciences), PD1 (BioLegend), and TIM3 (BioLegend).
All samples were counterstained with 7AAD (BioLegend) to exclude dead cells.
BD Celesta was used for cell acquisition, and data were analyzed using FlowJo V10 (Treestar). Representative plots showing the gating strategy are shown in Supplementary Figure 6A.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.